Oramed Pharmaceuticals Inc (ORMP)

Oramed Pharmaceuticals Inc (ORMP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $171M; returns 1 day +0.2%, 1 week +1.5%, 1 year +74.3%.

Oramed Pharmaceuticals Inc. (ORMP) is a clinical-stage biopharmaceutical company that is focused on the development of oral drug delivery systems, especially in the area of diabetes management. Oramed is working on transforming injectable therapies into oral formulations using its patented protein encapsulation technology called the Oral Delivery Platform.

Groups ORMP belongs to

• Clinical Stage Biopharma
• Biotechnology
• Metabolic Disorders
• Type 1 Diabetes
• GLP-1 Agonists
• Pharmaceuticals
• Clinical Stage
• Healthcare

ORMP financial model: income statement, cash flow and balance sheet